Alnylam Pharmaceuticals Inc
Company Profile
Business description
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia. It also has several clinical programs across various therapeutic areas: genetic medicines; cardio-metabolic diseases; hepatic infectious diseases, and CNS/ocular diseases. Upfront fees from research partnerships have boosted Alnylam's cash levels, and the company stands to see additional milestones and royalties from drugs commercialized under collaboration partnerships.
Contact
675 West Kendall Street
Henri A. Termeer Square
Cambridge MA 02142
USAT: +1 617 551-8200
E: INVESTORS@ALNYLAM.COM
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
2,100
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
---|---|---|---|
All Ordinaries | 8,153.40 | 59.10 | 0.73% |
CAC 40 | 7,517.68 | 90.66 | 1.22% |
DAX 40 | 18,417.55 | 118.83 | 0.65% |
Dow JONES (US) | 40,589.34 | 654.27 | 1.64% |
FTSE 100 | 8,285.71 | 99.36 | 1.21% |
HKSE | 17,021.31 | 16.34 | 0.10% |
NASDAQ | 17,357.88 | 176.16 | 1.03% |
Nikkei 225 | 37,667.41 | 202.10 | -0.53% |
NZX 50 Index | 12,349.47 | 46.80 | -0.38% |
S&P 500 | 5,459.10 | 59.88 | 1.11% |
S&P/ASX 200 | 7,921.30 | 60.10 | 0.76% |
SSE Composite Index | 2,890.90 | 4.16 | 0.14% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
---|---|---|---|
Bellevue Gold Ltd BGL | 1.44 | 0.40 | -21.58% |
Argosy Minerals Ltd AGY | 0.05 | 0.01 | 41.18% |
Red 5 Ltd RED | 0.38 | 0.02 | -5.06% |
Pilbara Minerals Ltd PLS | 2.98 | 0.11 | 3.83% |
Droneshield Ltd DRO | 1.40 | 0.09 | -6.04% |
Sayona Mining Ltd SYA | 0.03 | 0.00 | 0.00% |
Core Lithium Ltd CXO | 0.10 | 0.01 | 6.59% |
Zip Co Ltd ZIP | 1.78 | 0.04 | -1.93% |
South32 Ltd S32 | 2.98 | 0.07 | 2.41% |
Telstra Group Ltd TLS | 3.85 | 0.01 | 0.26% |